CTCL patients had higher circulating levels of IL-6, IL-8, IL-10, TGFβ, PGE2 and MMP7 which are factors released by tumor-associated macrophages in tumor microenvironment. This evidence concerns the gene TGFB1 and primary cutaneous T-cell non-Hodgkin lymphoma.